References
- Abouchedid, R., Gilks, T., Dargan, P. I., Archer, J. R., & Wood, D. M. (2018). Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances—benzodiazepines diclazepam, flubromazepam, and pyrazolam—in the UK. Journal of Medical Toxicology, 14(2), 134–143. doi: 10.1007/s13181-018-0659-3
- Battleday, R. M., & Brem, A. K. (2015). Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. European Neuropsychopharmacology, 25(11), 1865–1881. doi: 10.1016/j.euroneuro.2015.07.028
- British National Formulary (BNF) Online. (2018). Retrieved from https://www.medicinescomplete.com
- Boyd, S. E., Moore, L. S. P., Gilchrist, M., Costelloe, C., Castro-Sánchez, E., Franklin, B. D., & Holmes, A. H. (2017). Obtaining antibiotics online from within the UK: A cross-sectional study. Journal of Antimicrobial Chemotherapy, 72(5), 1521–1528. doi: 10.1093/jac/dkx003
- Carlyle, R. (2018, March 17). The disturbing rise of ‘study drugs. The Times. Retrieved from https://www.thetimes.co.uk/article/the-disturbing-rise-of-study-drugs-2sd73tf3b
- Clark, F. (2015). Rise in online pharmacies sees counterfeit drugs go global. The Lancet, 386(10001), 1327–1328. doi: 10.1016/S0140-6736(15)00394-3
- Crouch, H. (2018, June 19). Not so clever: What are smart drugs, are Modafinil and Ritalin illegal in the UK and what are the side effects? The Sun. Retrieved from https://www.thesun.co.uk/news/1952460/smart-drugs-modafinil-ritalin-side-effects
- d'Angelo, L., Camilla, S., Savulich, G., & Sahakian, B. J. (2017). Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure. British Journal of Pharmacology, 174, 3257–3267. doi: 10.1111/bph.13813
- Darwish, M., Kirby, M., Hellriegel, E. T., & Robertson, P. (2009). Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives. Clinical Drug Investigation, 29(9), 613–623. doi: 10.2165/11315280-000000000-00000
- Dean, J. (2013, November 22). In the City that never sleeps. . . traders stay up on ‘smart’ drugs. The Times. Retrieved from: https://www.thetimes.co.uk/article/in-the-city-that-never-sleeps-traders-stay-up-on-smart-drugs-bg2cts90rd8
- Dubljević, V., & Ryan, C. J. (2015). Cognitive enhancement with methylphenidate and modafinil: Conceptual advances and societal implications. Neuroscience and Neuroeconomics, 4, 25–33. doi: 10.2147/NAN.S61925
- Edwards, C. (2016, March 16). The rise of smart Drugs. Tatler. Retrieved from https://www.tatler.com/article/the-rise-of-smart-drugs
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol (2017). Drugs and the darknet: A growing threat to health and security. (News release No 18/2017). Retrieved from http://www.emcdda.europa.eu/news/2017/18/darknet-report_en
- Franke, A. G., Bagusat, C., Dietz, P., Hoffmann, I., Simon, P., Ulrich, R., & Lieb, K. (2013). Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Medicine, 11(1), 102. doi: 10.1186/1741-7015-11-102
- General Pharmaceutical Council. (2019). Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet. Retrieved from www.pharmacyregulation.org/sites/default/files/document/guidance_for_registered_pharmacies_providing_pharmacy_services_at_a_distance_including_on_the_internet_april_2019.pdf
- Hanson, C. L., Burton, S. H., Giraud-Carrier, C., West, J. H., Barnes, M. D., & Hansen, B. (2013). Tweaking and tweeting: Exploring Twitter for nonmedical use of a psychostimulant drug (Adderall) among college students. Journal of Medical Internet Research, 15(4), e62. doi: 10.2196/jmir.2503
- Hillebrand, J., Olszewski, D., & Sedefov, R. (2010). Legal highs on the Internet. Substance Use & Misuse, 45, 330–340. doi: 10.3109/10826080903443628
- Interpol. (2019). Pharmaceutical crime operations. Retrieved from https://www.interpol.int/Crimes/Illicit-goods/Pharmaceutical-crime-operations
- Krishnan, R., & Chary, K. V. (2015). A rare case modafinil dependence. Journal of Pharmacology and Pharmacotherapeutics, 6, 49. doi:10.4103%2F0976-500X.149149
- Medicaid. (2018). National average drug acquisition cost. Retrieved from: https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2018-08-29/8b63-w5qx
- Morton, W. A., & Stock, G. G. (2000). Methylphenidate abuse and psychiatric side effects. The Primary Care Companion to the Journal of Clinical Psychiatry, 02(05), 159. doi: 10.4088/PCC.v02n0502
- Nicholson, P. J., & Wilson, N. (2017). Smart drugs: Implications for general practice. British Journal of General Practice, 67(656), 100–101. doi: 10.3399/bjgp17X689437
- Nizar, H., Dargan, P. I., & Wood, D. M. (2015). Using Internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4, 4′-dimethylaminorex. Journal of Medical Toxicology, 11(1), 80–84. doi: 10.1007/s13181-014-0425-0
- Novak, S. P., Håkansson, A., Martinez-Raga, J., Reimer, J., Krotki, K., & Varughese, S. (2016). Nonmedical use of prescription drugs in the European Union. BMC Psychiatry, 16(1), 274. doi: 10.1186/s12888-016-0909-3
- Owen, D. R., Wood, D. M., Archer, J. R., & Dargan, P. I. (2016). Phenibut (4‐amino‐3‐phenyl‐butyric acid): Availability, prevalence of use, desired effects and acute toxicity. Drug and Alcohol Review, 35(5), 591–596. doi: 10.1111/dar.12356
- Plimmer, G. (2015, June 4). Smart drugs’ offer the ambitious an extra edge. Financial Times. Retrieved from: https://www.ft.com/content/0ac52ea2-fd4e-11e4-9e96-00144feabdc0
- Repantis, D., Schlattmann, P., Laisney, O., & Heuser, I. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research, 62(3), 187–206. doi: 10.1016/j.phrs.2010.04.002
- Reuters. (2018). Currency calculator. Retrieved from: https://www.reuters.com/finance/currencies
- Siddiqi, S., Verney, C., Dargan, P., & Wood, D. M. (2015). Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. Clinical Toxicology, 53(1), 54–59. doi: 10.3109/15563650.2014.983239
- Swapnajeet, S., Subodh, B. N., & Gourav, G. (2016). Modafinil dependence and hypersexuality: A case report and review of the evidence. Clinical Psychopharmacology and Neuroscience, 14(4), 402. doi:10.9758%2Fcpn.2016.14.4.402
- UK Government: Misuse of Drugs Act 1971. Retrieved from http://www.legislation.gov.uk/ukpga/1971/38/contents
- UK Government: The Misuse of Drugs Regulations 2001. Retrieved from http://www.legislation.gov.uk/uksi/2001/3998/contents/made
- UK Government: The Human Medicines Regulations 2012. Retrieved from http://www.legislation.gov.uk/uksi/2012/1916/regulation/214/made
- Urban, D., Rowell, K., & Kiryango, T. (2018, June 16). 'Smart drugs' epidemic as one in 12 adults admit taking them - with most trying them at work. The Telegraph. Retrieved from https://www.telegraph.co.uk/news/2018/06/15/smart-drug-epidemic-one-12-adults-admit-taking-trying-work
- Vermette-Marcotte, A. E., Dargan, P. I., Archer, J. R. H., Gosselin, S., & Wood, D. M. (2014). An Internet snapshot study to compare the international availability of the novel psychoactive substance methiopropamine. Clinical Toxicology, 52(7), 678–681. doi: 10.3109/15563650.2014.933346
- Wood, D. M., & Dargan, P. I. (2012). Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clinical Toxicology, 50(8), 727–732. doi: 10.3109/15563650.2012.716158